
Bronstein, Gewirtz & Grossman, LLC Launches Investigation: A Closer Look at the Company Initiating Inquiries
Bronstein, Gewirtz & Grossman, LLC Investigates Potential Securities Fraud Claims Against Sage Therapeutics, Inc. NEW YORK, NY – In a recent press release on March 9, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent securities fraud class action law firm, announced that it is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc….